Alto Neuroscience ANRO Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's accrued expenses?
- Alto Neuroscience (ANRO) reported accrued expenses of $2M in Q1 2026.
- How has Alto Neuroscience's accrued expenses changed year-over-year?
- Alto Neuroscience's accrued expenses decreased by 1.8% year-over-year, from $2.04M to $2M.
- What is the long-term trend for Alto Neuroscience's accrued expenses?
- Over 2 years (2023 to 2025), Alto Neuroscience's accrued expenses has grown at a 3.6% compound annual growth rate (CAGR), from $4.54M to $4.87M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.